Jürgen Kuball
jkuball.bsky.social
Jürgen Kuball
@jkuball.bsky.social
Chair of the Department of Hematology UMC Utrecht, NL, and Principle investigator interested in biology of gdT cells and allogeneic stem cell transplantation.
🧬 Proud to share our latest review in Nature Cancer Reviews! Our article, "Disrupting the balance between activating and inhibitory receptors of γδT cells for effective cancer immunotherapy", highlights a powerful but often overlooked player in the immunotherapy landscape.

rdcu.be/eo4RX
Disrupting the balance between activating and inhibitory receptors of γδT cells for effective cancer immunotherapy
Nature Reviews Cancer - In this Review, Beringer and colleagues highlight how future strategies for developing immunotherapies using γδT cells and their receptors will depend on creating...
rdcu.be
June 2, 2025 at 1:59 PM
Major achievement of the GoCART Coalition and all authors to release the 2025 edition of the EU CAR-T handbook at #EBMT25. Thx to my co-editors, all authors, EBMT and EHA to support this amazing project that will allow to develop the CART passport! Enjoy reading 😀. www.ebmt.org/education/ca...
The EU CAR-T Handbook
www.ebmt.org
March 29, 2025 at 10:26 PM
Reposted by Jürgen Kuball
March 11, 2025 at 8:33 AM
Still hot and happening: academic MSC for GVHD, a study of the CTIWP of The EBMT
rdcu.be/eaCcY
The use of MSCs in steroid-refractory acute GvHD in Europe: a survey from the EBMT cellular therapy & immunobiology working party
Bone Marrow Transplantation - The use of MSCs in steroid-refractory acute GvHD in Europe: a survey from the EBMT cellular therapy & immunobiology working party
rdcu.be
February 20, 2025 at 2:20 PM
🚀 Fresh off the pre-proof! 🚀
Excited to share our latest work, now available in Blood Reviews
✅ Immune monitoring is widely implemented but still lacks standardization.
✅ There is an urgent need for harmonized protocols to optimize patient outcomes.

www.sciencedirect.com/science/arti...
The landscape of immune monitoring in CAR-T cell therapy: A comprehensive review and survey study by the Cellular Therapy and Immunobiology Working Party of the EBMT
Immune monitoring of cell therapies is a complex and evolving topic, particularly in the rapid expanding field of chimeric antigen receptor T (CAR-T) …
www.sciencedirect.com
February 16, 2025 at 12:49 PM
Christian Chabannon presenting on the progress of #GoCARTcoalition a European initiative aiming to increase access to this exciting new therapies to cancer patients and patients with auto immune diseases. #EBMT #EHA #CART25
February 7, 2025 at 7:41 AM
What a great pre meeting before #CART25 in Strassbourg of #T2Evolve and #GoCART coalition on developing consensus on collected CART data as well as registry interactions using OMOPing
February 6, 2025 at 10:24 AM
We are proud to inform you that the survey about the CAR-T process has resulted in a stunning 227 response. Curious about first data: please join the session at QM Day April 1 at the EBMT congress in Florence, Italy!

#EBMT #JACIE #CART #GOCARTcoalition #HEMATOLOGY

lnkd.in/gQ8dQaps
LinkedIn
This link will take you to a page that’s not on LinkedIn
lnkd.in
February 4, 2025 at 1:27 PM
Congrats to the winners!!! Studies with real world data on CART are so important to improve clinical practice. Looking forward to the outcome of these studies thegocartcoalition.com
January 20, 2025 at 11:00 AM
Proud of Anke Janssen who finalized her PhD on the biology of gdT cells and their receptors for cancer in immunotherapies. Yuca also to the co-promotors Dennis Beringer and Moniek de Witte

research.umcutrecht.nl/news/%CE%B3%...
December 17, 2024 at 11:28 AM
Excellent presentation of ⁦‪@CChabannon‬⁩ on tisagenlecleucel for the Management of Patients with R/R DLBCL: an Interim Report of the European PASS Conducted
by EBMT ⁦at #ASH24
December 10, 2024 at 6:12 PM
Thx for picking up our work on MSC for GVHD at #ASH24 …. Still an interesting option
December 10, 2024 at 5:49 PM
#ASH24 Fantastic E. Donnall Thomas Lecture given by Sean Morrison on Hematopoietc Stem Cell Maintenance!
December 9, 2024 at 7:07 PM
Reposted by Jürgen Kuball
Dr. Ing Soo Tiong from @petermaccc.bsky.social presenting his excellent work at #ASH24 on how the remission clonal haematopoietic landscape is shaped by venetoclax in pts with AML. TP53 and BAX microclones! With a bit more sensitive sequencing tech we will find the nanoclones… #hemepath #hemesky
December 7, 2024 at 7:17 PM
Starting #ASH24 on Bluesky 😎
December 7, 2024 at 4:30 PM